| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Biology, California Institute of Technology, Pasadena, California 91125, USA
Abstract
This is a personal account of the early history of ubiquitin research, by one of its protagonists. The field of ubiquitin and regulated protein degradation was created in the 1980s, largely through the complementary discoveries by the laboratory of A. Hershko (Technion, Haifa, Israel) and by my laboratory, then at MIT (Cambridge, MA). I describe the elegant insights by Hershko and his colleagues that yielded the initial understanding of ubiquitin conjugation and ubiquitin-mediated proteolysis in cell extracts, including the identification of E1, E2, and E3 enzymes. These advances were followed by a set of interconnected discoveries in my laboratory that revealed the biology of the ubiquitin system, i.e., its necessity for the protein degradation in vivo, its specific physiological functions (in the cell cycle, DNA repair, protein synthesis, transcriptional regulation, and stress responses), the source of its selectivity (specific degradation signals in short-lived proteins), and its key mechanistic attributes, such as the polyubiquitin chain and the subunit selectivity of protein degradation. The above biological (function-based) insights produced the main discovery of the physiological regulation by intracellular protein degradation. These advances caused the enormous expansion of the ubiquitin field in the 1990s. Together with the initial discovery of ubiquitin-mediated proteolysis by Hershko and coworkers, our biological discoveries in the 1980s led to a radically changed understanding of the logic of intracellular circuits, as it became clear that the control through regulated protein degradation rivals, and often surpasses in significance, the classical regulation through transcription and translation.
Keywords: ubiquitin; proteasome; proteolysis; N-end rule; nitric oxide
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.052012306.
Reprint requests to: Alexander Varshavsky, Division of Biology, 147-75, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA; e-mail: avarsh{at}caltech.edu; fax: (626) 440-9821.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Schnupf, J. Zhou, A. Varshavsky, and D. A. Portnoy Listeriolysin O Secreted by Listeria monocytogenes into the Host Cell Cytosol Is Degraded by the N-End Rule Pathway Infect. Immun., November 1, 2007; 75(11): 5135 - 5147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Mtango and K. E. Latham Ubiquitin proteasome pathway gene expression varies in rhesus monkey oocytes and embryos of different developmental potential Physiol Genomics, September 11, 2007; 31(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-G. Hu, C. S. Brower, H. Wang, I. V. Davydov, J. Sheng, J. Zhou, Y. T. Kwon, and A. Varshavsky Arginyltransferase, Its Specificity, Putative Substrates, Bidirectional Promoter, and Splicing-derived Isoforms J. Biol. Chem., October 27, 2006; 281(43): 32559 - 32573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. An, J. W. Seo, T. Tasaki, M. J. Lee, A. Varshavsky, and Y. T. Kwon Impaired neurogenesis and cardiovascular development in mice lacking the E3 ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway PNAS, April 18, 2006; 103(16): 6212 - 6217. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
